Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
J Cancer Res Clin Oncol
    October 2022
  1. KIM DS, Kim HJ, Ahn HS
    Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database.
    J Cancer Res Clin Oncol. 2022;148:2855-2865.
    >> Share

    September 2022
  2. PARK SG, Ji MJ, Ham IH, Shin YH, et al
    Secretome analysis reveals reduced expression of COL4A2 in hypoxic cancer-associated fibroblasts with a tumor-promoting function in gastric cancer.
    J Cancer Res Clin Oncol. 2022 Sep 20. pii: 10.1007/s00432-022-04361.
    >> Share

  3. ZHANG Y, Zhao ZX, Gao JP, Huang YK, et al
    Tumor-infiltrating CD226(+)CD8(+) T cells are associated with postoperative prognosis and adjuvant chemotherapeutic benefits in gastric cancer patients.
    J Cancer Res Clin Oncol. 2022 Sep 15. pii: 10.1007/s00432-022-04346.
    >> Share

  4. KRIEG S, Roderburg C, Fung S, Luedde T, et al
    Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis.
    J Cancer Res Clin Oncol. 2022;148:2235-2246.
    >> Share

    August 2022
  5. XU C, Xie X, Kang N, Jiang H, et al
    Neoadjuvant PD-1 inhibitor and apatinib combined with S-1 plus oxaliplatin for locally advanced gastric cancer patients: a multicentered, prospective, cohort study.
    J Cancer Res Clin Oncol. 2022 Aug 30. pii: 10.1007/s00432-022-04302.
    >> Share

  6. LIU Y, Da M
    Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-beta and enhances chemoradiotherapy resistance.
    J Cancer Res Clin Oncol. 2022 Aug 28. pii: 10.1007/s00432-022-04320.
    >> Share

  7. KOLBE K, Haffner I, Schierle K, Maier D, et al
    Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study.
    J Cancer Res Clin Oncol. 2022 Aug 27. pii: 10.1007/s00432-022-04208.
    >> Share

    July 2022
  8. RUAN C, Meng Y, Song H
    CD36: an emerging therapeutic target for cancer and its molecular mechanisms.
    J Cancer Res Clin Oncol. 2022;148:1551-1558.
    >> Share

  9. MARGALIT O, Yu S, Shacham-Shmueli E, Strauss G, et al
    Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2022;148:1703-1708.
    >> Share

  10. LIU HY, Wang FH, Liang JM, Xiang YY, et al
    Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer.
    J Cancer Res Clin Oncol. 2022 Jul 1. pii: 10.1007/s00432-022-04124.
    >> Share

    June 2022
  11. BAFUTTO AAF, Castro OAP, Fukuhara DK, de Freitas WR Jr, et al
    Lymph node distribution in patients with remnant gastric cancer.
    J Cancer Res Clin Oncol. 2022 Jun 21. pii: 10.1007/s00432-022-04104.
    >> Share

  12. LIU SJ, Huang PD, Xu JM, Li Q, et al
    Diet and gastric cancer risk: an umbrella review of systematic reviews and meta-analyses of prospective cohort studies.
    J Cancer Res Clin Oncol. 2022 Jun 13. pii: 10.1007/s00432-022-04005.
    >> Share

    May 2022
  13. MYER NM, Shitara K, Chung HC, Lordick F, et al
    Evolution of predictive and prognostic biomarkers in the treatment of advanced gastric cancer.
    J Cancer Res Clin Oncol. 2022 May 13. pii: 10.1007/s00432-021-03902.
    >> Share

  14. TOYA Y, Shimada T, Hamada K, Watanabe K, et al
    Prediction model of 3-year survival after endoscopic submucosal dissection for early gastric cancer in elderly patients aged >/= 85 years: EGC-2 model.
    J Cancer Res Clin Oncol. 2022 May 11. pii: 10.1007/s00432-022-04024.
    >> Share

    April 2022
  15. SHIMOZAKI K, Shinozaki E, Yamamoto N, Imamura Y, et al
    KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
    J Cancer Res Clin Oncol. 2022 Apr 19. pii: 10.1007/s00432-022-03966.
    >> Share

  16. LIU YY, Ruan GT, Ge YZ, Li QQ, et al
    Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer.
    J Cancer Res Clin Oncol. 2022 Apr 18. pii: 10.1007/s00432-022-03925.
    >> Share

  17. ATTARD TM, Omar U, Glynn EF, Stoecklein N, et al
    Gastric cancer in the pediatric population, a multicenter cross-sectional analysis of presentation and coexisting comorbidities.
    J Cancer Res Clin Oncol. 2022 Apr 18. pii: 10.1007/s00432-022-03972.
    >> Share

    March 2022
  18. WANG X, Che K, Shi T, Liu Q, et al
    Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.
    J Cancer Res Clin Oncol. 2022 Mar 16. pii: 10.1007/s00432-022-03971.
    >> Share

  19. MAEKAWA A, Kudo A, Kishino M, Murase Y, et al
    Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy.
    J Cancer Res Clin Oncol. 2022;148:697-706.
    >> Share

    February 2022
  20. STOLZE T, Franke S, Haybaeck J, Moehler M, et al
    Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis.
    J Cancer Res Clin Oncol. 2022 Feb 25. pii: 10.1007/s00432-022-03953.
    >> Share

    January 2022
  21. WONG Y, Meehan MT, Burrows SR, Doolan DL, et al
    Estimating the global burden of Epstein-Barr virus-related cancers.
    J Cancer Res Clin Oncol. 2022;148:31-46.
    >> Share

  22. WANG C, Zhao D, Shu X, Wang K, et al
    Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10-pyruvate carboxylase axis.
    J Cancer Res Clin Oncol. 2022;148:121-135.
    >> Share

    December 2021
  23. CHEN Y, Huang Y, Zhu L, Chen M, et al
    Correction to: SOX2 inhibits metastasis in gastric cancer.
    J Cancer Res Clin Oncol. 2021 Dec 22. pii: 10.1007/s00432-021-03863.
    >> Share

    September 2021
  24. PAN Z, Fu Z, Luo C, Bao Y, et al
    CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
    J Cancer Res Clin Oncol. 2021 Sep 18. pii: 10.1007/s00432-021-03775.
    >> Share

    May 2021
  25. XIE J, Pang Y, Li X, Wu X, et al
    The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
    J Cancer Res Clin Oncol. 2021 May 18. pii: 10.1007/s00432-021-03654.
    >> Share

  26. LIU Z, Shi M, Li X, Song S, et al
    HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:1315-1324.
    >> Share

    April 2021
  27. ZHANG Y, Wang F, Sun HR, Huang YK, et al
    Apatinib combined with PD-L1 blockade synergistically enhances antitumor immune responses and promotes HEV formation in gastric cancer.
    J Cancer Res Clin Oncol. 2021 Apr 23. pii: 10.1007/s00432-021-03633.
    >> Share

  28. WAN Q, Zhao R, Xia L, Wu Y, et al
    Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies.
    J Cancer Res Clin Oncol. 2021;147:1077-1087.
    >> Share

    March 2021
  29. ZHANG Q, Ni Y, Zhi X, Wang J, et al
    Involvement of APRIL in Helicobacter pylori-related gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 18. pii: 10.1007/s00432-021-03574.
    >> Share

  30. NA JE, Lee H, Min YW, Min BH, et al
    Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer.
    J Cancer Res Clin Oncol. 2021 Mar 5. pii: 10.1007/s00432-021-03581.
    >> Share

    February 2021
  31. JIANG L, Gong X, Liao W, Lv N, et al
    Molecular targeted treatment and drug delivery system for gastric cancer.
    J Cancer Res Clin Oncol. 2021 Feb 7. pii: 10.1007/s00432-021-03520.
    >> Share

  32. OHNUMA H, Sato Y, Onoyama N, Hamaguchi K, et al
    Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis.
    J Cancer Res Clin Oncol. 2021 Feb 3. pii: 10.1007/s00432-021-03516.
    >> Share

    January 2021
  33. FAN Y, Liu M, Li S, Yu J, et al
    Surgical and oncological efficacy of laparoscopic-assisted total gastrectomy versus open total gastrectomy for gastric cancer by propensity score matching: a retrospective comparative study.
    J Cancer Res Clin Oncol. 2021 Jan 7. pii: 10.1007/s00432-020-03503.
    >> Share

  34. SUN Y, He J, Shi DB, Zhang H, et al
    Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2021;147:105-115.
    >> Share

    August 2020
  35. JIN P, Ji X, Ma S, Kang W, et al
    Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience.
    J Cancer Res Clin Oncol. 2020 Aug 9. pii: 10.1007/s00432-020-03355.
    >> Share

  36. MA F, Wang B, Xue L, Kang W, et al
    Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
    J Cancer Res Clin Oncol. 2020;146:2135-2142.
    >> Share

    July 2020
  37. RAMOS MFKP, Pereira MA, de Castria TB, Ribeiro RRE, et al
    Remnant gastric cancer: a neglected group with high potential for immunotherapy.
    J Cancer Res Clin Oncol. 2020 Jul 15. pii: 10.1007/s00432-020-03322.
    >> Share

  38. JIN P, Ji X, Kang W, Li Y, et al
    Artificial intelligence in gastric cancer: a systematic review.
    J Cancer Res Clin Oncol. 2020 Jul 1. pii: 10.1007/s00432-020-03304.
    >> Share

    May 2020
  39. CHENG L, Chen S, Wu W, Kuo ZC, et al
    Gastric cancer in young patients: a separate entity with aggressive features and poor prognosis.
    J Cancer Res Clin Oncol. 2020 May 25. pii: 10.1007/s00432-020-03268.
    >> Share

    March 2020
  40. XIE W, Zhou H, Han Q, Sun T, et al
    Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes.
    J Cancer Res Clin Oncol. 2020 Mar 6. pii: 10.1007/s00432-020-03171.
    >> Share

    February 2020
  41. LIU X, Lin K, Huang X, Xie W, et al
    Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis.
    J Cancer Res Clin Oncol. 2020 Feb 5. pii: 10.1007/s00432-019-03092.
    >> Share

  42. DONG Y, Qiu Y, Deng J, Wang W, et al
    Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation.
    J Cancer Res Clin Oncol. 2020;146:515-528.
    >> Share

    January 2020
  43. ZHANG C, Lin X, Zhao Q, Wang Y, et al
    YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
    J Cancer Res Clin Oncol. 2020 Jan 8. pii: 10.1007/s00432-019-03115.
    >> Share

    November 2019
  44. MAEZAWA Y, Sakamaki K, Oue N, Kimura Y, et al
    High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.
    J Cancer Res Clin Oncol. 2019 Nov 21. pii: 10.1007/s00432-019-03087.
    >> Share

  45. CLAUSEN F, Behrens HM, Kruger S, Rocken C, et al
    Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women.
    J Cancer Res Clin Oncol. 2019 Nov 19. pii: 10.1007/s00432-019-03082.
    >> Share

    October 2019
  46. LI Q, Lv M, Jiang H, Wang Y, et al
    A prospective observational study on the optimal maintenance strategy in HER2-positive advanced gastric cancer treated with trastuzumab-based therapy.
    J Cancer Res Clin Oncol. 2019 Oct 30. pii: 10.1007/s00432-019-03060.
    >> Share

  47. LI J, Xu H, Zhang L, Song L, et al
    Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.
    J Cancer Res Clin Oncol. 2019 Oct 9. pii: 10.1007/s00432-019-03004.
    >> Share

  48. KAJTAZI Y, Kaemmerer D, Sanger J, Schulz S, et al
    Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
    J Cancer Res Clin Oncol. 2019;145:2481-2493.
    >> Share

    September 2019
  49. BOSCH F, Todorova R, Link H, Westphalen CB, et al
    Molecular subtyping of gastric cancer with respect to the growth pattern of lymph-node metastases.
    J Cancer Res Clin Oncol. 2019 Sep 20. pii: 10.1007/s00432-019-03029.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016